Related Experiment Videos
Psychophysiological study on fasting therapy
Psychotherapy and Psychosomatics
|January 1, 1979
Summary
Fasting therapy, a method from Tohoku University, showed an 87% efficacy rate in 380 patients, particularly for psychosomatic conditions. This therapy may activate the body's natural healing power through ketone nutrition, promoting homeostasis.
Area of Science:
- Integrative Medicine
- Neuroscience
- Endocrinology
Background:
- Fasting therapy is increasingly recognized for its potential health benefits.
- Understanding the therapeutic mechanisms of fasting is crucial for its clinical application.
- Psychosomatic diseases present complex challenges in treatment.
Purpose of the Study:
- To evaluate the clinical efficacy of the Tohoku University method of fasting therapy.
- To investigate the underlying therapeutic mechanisms of fasting therapy.
- To identify suitable indications for fasting therapy.
Main Methods:
- A cohort of 380 patients underwent the Tohoku University fasting therapy.
- Clinical outcomes were assessed, yielding an overall efficacy rate.
- Electroencephalogram (EEG) power spectral analysis and urinary 17-hydroxycorticosteroids (17-OHCS) measurements were performed before, during, and after therapy.
Main Results:
- An 87% efficacy rate was observed across the patient cohort.
- Fasting therapy demonstrated effectiveness for conditions including irritable colon syndrome, neurocirculatory asthenia, mild diabetes mellitus, obesity, and borderline hypertension.
- EEG analysis showed decreased peak frequency during fasting and increased alpha wave energy post-therapy. Dexamethasone suppression rate of urine 17-OHCS was significantly lower after therapy.
Conclusions:
- Fasting therapy, particularly via ketone nutrition, may act as a stressor that activates the body's inherent healing mechanisms.
- This process appears to induce a temporary stress state, ultimately promoting homeostasis.
- The findings support fasting therapy as a viable treatment for specific psychosomatic and metabolic conditions.